Pressurl: https://news.google.com/rss/articles/CBMihgJBVV95cUxPVERjSmsyenJTTlhzdmlUcTlCbDcxSUF4UGZlSnV4YU9GVm1VUzZHMERNcDlQeDlYeDZrclhBajI1azJoVnlURmVfb3lob3VGWnNQY1hkSVA2VHB1S3E0cnFpa3YzZzRoR2J0Z1AtUV83YTVlb0F0VGMxdHVManEwNWlrYWd1bnZuLXdCNEo1cHpVcVBzcWlYU0ZELVZFSkdJSW5KVGpmYWx4OXpLZnlOWERXQk9UZVlPbmczWFpEa3dzX04ydFpWX0hZRUQxZVdsckRLa3pGdEM1WW5oSkJ0ekE0eVBwb2ppZnNYVGYyNVJmWTI2cjlNRTIyTk91ZVNrVENJSzRR?oc=5 · headline: Ray Therapeutics and Forge Biologics Expand Their Viral Vector cGMP Partnership to Encompass Plasmid DNA Manufacturing · publication: Business Wiregoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMi0gFBVV95cUxOV2NkTmE3bVk3RV9BLXVMdGxIaHBac3d6RzR0aTIycm1HWjdzZU1TdkRaUVlWQ04yZHV3eVpCZGNHeXp0dWFEMXNIdVRLS19sSURBVE9JcVM1R2hiVXlTTjZ0R2x4RnM5ZU0xMlE4dUg4My1UUXdRWWlzVjhUVXJhZWpGUU1DckY3UXBpOFpXMjRjY2FkcG5aZG9oMVk0bG5LRE45OHhycnBBWWtkR2V3Zlk5cHBtUGZLQW5WTHViUHRRanNpWi1OQ1JYdUo2Z01JRWc?oc=5 · headline: Ray Therapeutics Announces Promotion of Jenny Holt to Chief Development Officer · publication: Business Wiregoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMi8gFBVV95cUxObWpDcnpoalhrNDRWa3Z0bTBsZmtjYzBOVWhFbmxBUEgydnN0b1VXTVRoQ1VaTXVFU2xfSmxyci1SdnB4OXJmdExCRlBLWnA4SVJfUldJSUFlQnRWRDNoWk52TW1VOGxFVFlybmFfLVZyWTRHSVFXWnM5U0tmdXJGVTBwSTR2MWVSTkdVdG5hdXJ0SUJHYUJ4SWo3RUZEcV93TzEwZ1QzME90RWVyeW01cEFLMTdNbC1OVUFhelhWQ3F1TTRVRGx0eUVMMGRFWUR5ZFVMRVU2dEZyZmJqSUpxMXFqa1lTWkRWdllJMkVwVDA4UQ?oc=5 · headline: Ray Therapeutics Receives $4M in Funding from The California Institute for Regenerative Medicine (CIRM) · publication: Business Wiregoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMiygFBVV95cUxNbXEyZmZvOUV1MlhNUGZyeE9BSHBGXzlpMFdwdjlGQWJUWlQtclMwWEVzalJQalI0Tzh2b1FXTktPLWMySzZwRjdPSkxJOFRiYXlhbHV3X1V3MktOUFdwWkJiMzNKcThPMjFoYmVLMXJISXRVN2dfUXY1dkJDcTRVR3NsaG5xVFpXY2tGTTdZLU5CZXJmU195RVg4YjhNTzdteS1iR0o2aVlHcUJGZ0hwRDNzZDQ4Y0ljMTdqQUNqMktaUGpDU1AyMlJ3?oc=5 · headline: Ray Therapeutics Appoints Christopher Whitmore as Chief Financial Officer · publication: Business Wire
google_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMi6wFBVV95cUxPUmxjYVVZWi02a0F0RTZSNjMwNWRYZ0ZTWVlSc2JISnZxNVpCS05tVUdnODFNcE82MUVCTFJ2dkY0bmRKN1lGMk15dXZJd1ZvUThQZnZEbGFrZUszSDFMUVRfcmhDWEZFd0I4VVdUa0ZGX2N6a083a2lDa2xESHBBVjZOSmE4NXZEVnh1VzZYeEJpcGN2d2dYdmhzYzFPRV9NM1RVSmYya1Bkc0ZkT1BSa1BPWVUtMjFHa0U0akFZR3BCeHVPTTNkWnA2Q0Y1SDFkTkhiOW5DQzZmUmlrb2xIWFVUT0FuM1Nqbjlz?oc=5 · headline: Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa · publication: Business Wiregoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMiigJBVV95cUxNNzZSSmlpT2kzOGF5ZkdjbEdXOFdrZmltYXVZaVdIMk9haEh5MG0yelFpZUVWUHg5QW13LXFyRHE1Y3VJNW41UnJieGZuWEMybWVQZlEzdlEyeDZmS0JkRk1rWUxodG9nRWN2ekhjQ0dkdHcwRDFveFFDaVRhSXd1U3U4R215TmZvbWZKdnJYa1JHLWlaZUxSYjB4c0ZSNG9RMTJNeG44aV9jb0Y3bU5KREFtWlgyWndpUUhDSURYYWQySnNBeE9HeGtpamQyclJNUm15MkhfQTVHQTlPZFpVUFNMMmVSbGlBSlIwcnZIaDNkeHFRcHNaZjhjV3prbDJ2MWtNMi1FMDVoUQ?oc=5 · headline: Ray Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RTx-015 in Retinitis Pigmentosa · publication: Business Wiregoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMikgFBVV95cUxORWVHUzdMc3JTSk5RQS1KcnczUWk3V0QzY25oQ29GTElTUzBFYkpxNFFGSG5IeFNSVW9acDk5WmVoODlGUEFRS2g4VmpldnpRT09RdFVOVnRTYVZmSk96X2lidWFWY2ZSUG5UMVpqZHdSd1Z3MHhrcWxMR0xTWEZDblBfNFkwVU4yTkFWSnlqMmtsdw?oc=5 · headline: Ray Therapeutics Appoints Scott Braunstein, M.D., as Chairman of the Board of Directors · publication: Yahoo Financegoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMimAJBVV95cUxOVUxkaGllV2thRjYtYVRWZ3FsWWw1Z3NMa0FyRkJ2Y2QyMjlUZU53MDJrRnhUWTh1VkJQM1dyOE1VSzRISTFiMDlCRmZJNnRZc212QjM3bzBvMExDY3FpRkloUFp4Z1JubzJYeVlhbUJZbEs5X196dHEtNHFiam5ic0FaZi1ySGdaN0hCeXp3NjVVYy1pUkxVdkpBZDZKYlhURGxPMllrUkxvN1htYU5rWHV6MHZ3bGVKOXVnY193eHY0bXRSMTNoRDdxOXc0UkJGMGsyTGtUYjBXRFhvRXNSQ2kxdHFBN3J2VUJ0R0FpcGdkYVhfbzBUZWpLV0t1RnBDZ0dLRVIxTG51VllhY292NGtYd1dfWTY3?oc=5 · headline: Ray Therapeutics Granted Priority Medicines (PRIME) Designation from the European Medicines Agency for RTx-015 in Retinitis Pigmentosa · publication: Business Wiregoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMilwFBVV95cUxQUmRYZ1NXZXNZcGFEUXhYUE4zdGZnWm5fNTJfbkRUS3RKYjV1b29tcFZvb1piTUU1YnF5RlcxQmFWWlZaYjg3dWx2RVFTMGdQcU9tVE5FeHc5TTJRWVNTcEZiWUU3aG50anVXY01jVnJzYlVmR0NlUUxVTGs5X3RhOS1ZRmtEcTNxZXRUU0ZmTndBTkgtVlFz?oc=5 · headline: C-Ray Therapeutics receives FDA acceptance for copper-64 file · publication: vir.com.vngoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMivAFBVV95cUxOOTVGRWxFX2dXVW5kamw3cFRsdklNMk5RQlExNXluQkxOajFFeERBektKbU9YQWRxbFh0cTFWRWduQW9rN2ZUWTN5MWIxQmpyeDVVdXY1UzNIczFJcVlBbzFETmROVTRhRlNPb1dlMXY3WW9YdndCSXpHaUdweWZ2RVljSjhLRjFNM0hWSVc2VS1vVnJ5Zlpmd0FXb1M4U2lCSm1rdERobTZuS2kzazEzNzM3UHJGT1VkMlM4ZQ?oc=5 · headline: Novo Holdings leads $100M Series A Financing to Advance Gene Therapies for Blinding Diseases · publication: Novo Holdingsgoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMi1gFBVV95cUxPUXctYnZHaUt1dmt5YmV3TzV1WHpDTk1Pcjdpekd0YzhwdnYyRG5uajFjWVplOTBvTzZQTVV0d2dJUW15VnR5R0NUZmZ6aW1QY2ZuZFM1OF9JQ2ZJTGJSOWdCeTdBaTNnMFZuNDZvcENkSGpvRmNfQ0sta0k0c1ViNDV4clJ6N2VqbFZaR3FHWWZlNC1VZlZpS0NSWmRoUHdtQVE1UFdRWXhCOUJFYk5IUVZwSzl2T2xTaU5mQW5USlpZaXc5b2cwOE41U2xHcXdvOWswM3VB?oc=5 · headline: Ray Therapeutics Awarded $8 Million CIRM Grant to Advance RTx-021 Gene Therapy for Stargardt Disease · publication: BioSpacegoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMiwwJBVV95cUxPTEczd2h2WDJLQnRSRktJX2UzY0VQNmZCbGhueG9aQlNCQ2ZCemtJWElaRFVRWHJiS1RWV1Q0SjJWXzlMQm1MMkNnd2xvOUdTMnhwM2ViNGdMdTZOaG9LdkwtOHNUaF9TX3lYTzdqS29veXBydFlkbW1scmlsOHNKdlpsYTd6cmdJZndwSFRYVTltcWJUYWFZRTFiUnV6ZnRvLWY2QW55Q1NLbHQtYmFZXzBuWi1xYjZzdDU0Szd2TU5JRlpoLXZpUldoa1FYczNZMGlxdGMwOTFWQXZpNXltTDRMMWVrNVhBbUd6R19PTzcyN3hnakFjSktYUEVlcWVBMTc4ZXBfOExOaTFMaDlCMEF1LXVHRXdDbURyQ1puRzhhcWZNMWZUR3pGeXVmd2dBdU5mbnVlX2xoNmpMVkM5LWlJbw?oc=5 · headline: 4BIO Capital portfolio company Ray Therapeutics announces · publication: GlobeNewswiregoogle_news · 10/1/2026